Anne-chantal C. Knol

Nantes, 44093, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

Predictive factors of response to vismodegib: a French study of 61 patients with multiple or locally advanced basal cell carcinoma

Predictive factors of response to vismodegib: a French study of 61 patients with multiple or locally advanced basal cell carcinoma

Journal: European journal of dermatology : EJD
Published: September 06, 2022

Circulating Tumor DNA Early Kinetics Predict Response of Metastatic Melanoma to Anti-PD1 Immunotherapy: Validation Study.

Circulating Tumor DNA Early Kinetics Predict Response of Metastatic Melanoma to Anti-PD1 Immunotherapy: Validation Study.

Journal: Cancers
Published: March 06, 2021

Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic BRAF or NRAS-Mutated Melanoma Patients.

Circulating Tumour DNA Is an Independent Prognostic Biomarker for Survival in Metastatic BRAF or NRAS-Mutated Melanoma Patients.

Journal: Cancers
Published: June 10, 2020

Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial.

Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial.

Journal: Cancer immunology, immunotherapy : CII
Published: August 27, 2019

Effect of Indoleamine 2,3 Dioxygenase Inhibitor on the Cytotoxic Activity of Tumour-infiltrating Lymphocytes.

Effect of Indoleamine 2,3 Dioxygenase Inhibitor on the Cytotoxic Activity of Tumour-infiltrating Lymphocytes.

Journal: Acta dermato-venereologica
Published: August 14, 2019

Expression of Three Adipokines (Adiponectin, Leptin and Resistin) in Normal Canine Skin: a Pilot Study.

Expression of Three Adipokines (Adiponectin, Leptin and Resistin) in Normal Canine Skin: a Pilot Study.

Journal: Journal of comparative pathology
Published: September 05, 2018

Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy.

Quantitative monitoring of circulating tumor DNA predicts response of cutaneous metastatic melanoma to anti-PD1 immunotherapy.

Journal: Oncotarget
Published: March 02, 2018

Circulating tumour DNA: analytical aspects and clinical applications for metastatic melanoma patients.

Circulating tumour DNA: analytical aspects and clinical applications for metastatic melanoma patients.

Journal: Annales de biologie clinique
Published: December 02, 2017

BRAF mutations might be more common than supposed in vulvar melanomas.

BRAF mutations might be more common than supposed in vulvar melanomas.

Journal: Experimental dermatology
Published: October 26, 2017

Are checkpoint inhibitors a valuable option for metastatic or unresectable vulvar and vaginal melanomas?

Are checkpoint inhibitors a valuable option for metastatic or unresectable vulvar and vaginal melanomas?

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 28, 2017

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.

Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes in Advanced Melanoma Patients.

Journal: Journal of immunology research
Published: July 18, 2017

Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical Efficacy.

Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical Efficacy.

Journal: Cancer research
Published: June 21, 2017
Showing 1-12 of 38

Last Updated: 09/26/2026